Multidimensional Assessment of Functional Outcomes in Schizophrenia: Results From QUALIFY, a Head-to-Head Trial of Aripiprazole Once-Monthly and Paliperidone Palmitate

BACKGROUND: QUALIFY was a 28-week, randomized, open-label, head-to-head trial that assessed improvements across multiple measures in stable patients with schizophrenia with aripiprazole once-monthly 400 mg vs paliperidone palmitate. METHODS: Secondary effectiveness assessments included physician-rat...

Descripción completa

Detalles Bibliográficos
Autores principales: Potkin, Steven G., Loze, Jean-Yves, Forray, Carlos, Baker, Ross A, Sapin, Christophe, Peters-Strickland, Timothy, Beillat, Maud, Nylander, Anna-Greta, Hertel, Peter, Nitschky Schmidt, Simon, Eramo, Anna, Hansen, Karina, Naber, Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Regular Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578804/
https://www.ncbi.nlm.nih.gov/pubmed/27927736
http://dx.doi.org/10.1093/ijnp/pyw093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578804/
https://www.ncbi.nlm.nih.gov/pubmed/27927736
http://dx.doi.org/10.1093/ijnp/pyw093

Ejemplares similares